Published in Cognition on May 01, 2001
Evidence from an emerging sign language reveals that language supports spatial cognition. Proc Natl Acad Sci U S A (2010) 1.48
Children's spatial thinking: does talk about the spatial world matter? Dev Sci (2011) 1.34
Spatial representation across species: geometry, language, and maps. Curr Opin Neurobiol (2009) 1.08
Parametric Coding of the Size and Clutter of Natural Scenes in the Human Brain. Cereb Cortex (2014) 1.06
A modular geometric mechanism for reorientation in children. Cogn Psychol (2010) 1.05
Impaired geometric reorientation caused by genetic defect. Proc Natl Acad Sci U S A (2010) 1.03
Quantities, amounts, and the numerical core system. Front Hum Neurosci (2012) 1.00
Cognitive effects of language on human navigation. Cognition (2011) 1.00
Two systems of spatial representation underlying navigation. Exp Brain Res (2010) 0.96
Spatial language facilitates spatial cognition: evidence from children who lack language input. Cognition (2013) 0.93
Core systems of geometry in animal minds. Philos Trans R Soc Lond B Biol Sci (2012) 0.92
Processing ordinality and quantity: the case of developmental dyscalculia. PLoS One (2011) 0.84
The reach-to-grasp-food task for rats: a rare case of modularity in animal behavior? Behav Brain Res (2007) 0.84
Spatial and numerical abilities without a complete natural language. Neuropsychologia (2010) 0.79
Language supports young children's use of spatial relations to remember locations. Cognition (2016) 0.79
Framing the grid: effect of boundaries on grid cells and navigation. J Physiol (2016) 0.79
Spatial reorientation in large and small enclosures: comparative and developmental perspectives. Cogn Process (2008) 0.78
Producing Spatial Words Is Not Enough: Understanding the Relation Between Language and Spatial Cognition. Child Dev (2016) 0.77
Geometric and featural systems, separable and combined: Evidence from reorientation in people with Williams syndrome. Cognition (2015) 0.77
Does spatial locative comprehension predict landmark-based navigation? PLoS One (2015) 0.75
Self-locomotion and spatial language and spatial cognition: insights from typical and atypical development. Front Psychol (2014) 0.75
Visual spatial cue use for guiding orientation in two-to-three-year-old children. Front Psychol (2013) 0.75
The developmental trajectory of intramaze and extramaze landmark biases in spatial navigation: An unexpected journey. Dev Psychol (2015) 0.75
A new biomarker to examine the role of hippocampal function in the development of spatial reorientation in children: a review. Front Psychol (2015) 0.75
Rotational displacement skills in rhesus macaques (Macaca mulatta). J Comp Psychol (2012) 0.75
Spatial Impairment and Memory in Genetic Disorders: Insights from Mouse Models. Brain Sci (2017) 0.75
Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology (1994) 3.81
Familial occurrence of inflammatory bowel disease. N Engl J Med (1991) 2.95
Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology (1992) 2.86
An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis. Am J Gastroenterol (2001) 1.88
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol (1991) 1.73
Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease--a population-based study. Aliment Pharmacol Ther (2011) 1.53
Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ (1993) 1.34
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut (2013) 1.30
Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol (1997) 1.28
Ethical aspects of clinical trials: the attitudes of participants in two non-cancer trials. J Intern Med (2000) 1.28
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol (2003) 1.14
Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol (1996) 1.12
Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther (2004) 1.09
Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment Pharmacol Ther (2011) 1.07
Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study. Digestion (2007) 1.01
The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther (2013) 0.97
eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn’s disease. Aliment Pharmacol Ther (2012) 0.92
Magnetic resonance imaging of Crohn disease: early recognition of treatment response and relapse. Abdom Imaging (1997) 0.88
Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with IBD. Gut (2000) 0.86
Evaluation of treatment response in active Crohn's disease by low-field magnetic resonance imaging. Abdom Imaging (1999) 0.85
Active Crohn's disease and ulcerative colitis evaluated by low-field magnetic resonance imaging. Scand J Gastroenterol (1998) 0.85
Granulomas of the appendix: is it Crohn's disease? Scand J Gastroenterol (1991) 0.85
Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand J Gastroenterol (2002) 0.83
Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. Aliment Pharmacol Ther (2005) 0.81
Inflammatory bowel disease evaluated by low-field magnetic resonance imaging. Comparison with endoscopy, 99mTc-HMPAO leucocyte scintigraphy, conventional radiography and surgery. Scand J Gastroenterol (2002) 0.81
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age. Breast Cancer Res Treat (2000) 0.81
A new rapid home test for faecal calprotectin in ulcerative colitis. Aliment Pharmacol Ther (2009) 0.80
[Inflammatory bowel diseases in children]. Ugeskr Laeger (1998) 0.78
Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort. J Crohns Colitis (2008) 0.78
Infliximab dependency in children with Crohn's disease. Aliment Pharmacol Ther (2009) 0.76
Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis. Aliment Pharmacol Ther (2009) 0.76
Tolerability of interferon alpha-2b, a possible new treatment of active Crohn's disease. Aliment Pharmacol Ther (1995) 0.76
[Antibiotic treatment of traveller's diarrhea]. Ugeskr Laeger (1997) 0.75
[Therapeutic principles for chronic inflammatory bowel disease]. Ugeskr Laeger (2001) 0.75
[Long-term prognosis of patients with ulcerative colitis]. Ugeskr Laeger (1993) 0.75
Treatment of active distal ulcerative colitis with immunoglobulin G enemas. Aliment Pharmacol Ther (1993) 0.75